Journal of Clinical and Cellular Immunology

Journal of Clinical and Cellular Immunology
Open Access

ISSN: 2155-9899

+44 1223 790975

Ahmed Lasfar

Ahmed Lasfar

Ahmed Lasfar
University Hospital Cancer Center
University of Medicine and Dentistry of New Jersey, USA


Dr. Ahmed Lasfar is a Researcher working on improving the use of Interferon in cancer and determining the mechanisms of resistance to interferon therapy at the University Hospital Cancer Center New Jersey Medical School/University of Medicine and Dentistry of New Jersey. He is a member of the Department of Biochemistry and Molecular Biology at NJMS/UMDNJ. He has completed his Post Doctoral training 1999-2002 in the Department of Molecular Genetics Microbiology and Immunology at Robert Wood Johnson Medical School UMDNJ under the supervision of Dr. Sidney Pestka Leader for the approval of IFN use in Clinic by the FDA in 1986 and the winner of the National Medal of Technology in 2002. Dr. Ahmed lasfar has received a PhD in Immunology from Paris University of Science France in 1996. He has completed his Master Degree in Rene Descartes University School of Medicine France 1992. He received several awards including two excellence scientific awards from the New Jersey Commission on Cancer Research and one award from the International Society for Interferon and Cytokine Research.

Research Interest

- Interferon lambda signaling in normal and cancer cells
- Strategies for the improvement of interferon treatment in melanoma
- Role of Interferon lambdas in Hepatocelluar Carcinoma
- Mechanisms of TGF beta resistance
- Interaction between TGF beta and Interferons.